Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 17,486 shares at $8.33 ($146K) on 2023-02-15, disclosed to the SEC on 2023-02-17.
Open-market sale of $146k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.33 | 7,486 | $62K | 42.7% |
| 2 | $8.33 | 7,486 | $62K | 42.7% |
| 3 | $8.44 | 746 | $6K | 4.3% |
| 4 | $8.42 | 1,768 | $15K | 10.2% |
| Total | $8.34 avg | 17,486 | $146K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |